Published in Yonsei Med J on March 01, 2015
Pathogenesis of minimal change nephrotic syndrome: an immunological concept. Korean J Pediatr (2016) 0.77
Montelukast improves the changes of cytoskeletal and adaptor proteins of human podocytes by interleukin-13. Inflamm Res (2017) 0.75
A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol (2002) 6.48
Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol (1999) 5.06
Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta (2007) 4.74
Signalling to and from tight junctions. Nat Rev Mol Cell Biol (2003) 4.37
Nephrotic syndrome in childhood. Lancet (2003) 3.36
Podocyte biology and response to injury. J Am Soc Nephrol (2002) 3.25
The glomerular slit diaphragm is a modified adherens junction. J Am Soc Nephrol (2000) 2.99
The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium. J Cell Biol (1990) 2.95
PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane. J Clin Invest (1999) 2.67
Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med (1999) 2.53
Cell biology and pathology of podocytes. Annu Rev Physiol (2011) 2.42
ZO-1 stabilizes the tight junction solute barrier through coupling to the perijunctional cytoskeleton. Mol Biol Cell (2009) 2.10
Zonula occludens-1 and -2 are cytosolic scaffolds that regulate the assembly of cellular junctions. Ann N Y Acad Sci (2009) 1.96
Molecular architecture of adherens junctions. Curr Opin Cell Biol (2001) 1.94
Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol (2007) 1.67
The altered glomerular filtration slits seen in puromycin aminonucleoside nephrosis and protamine sulfate-treated rats contain the tight junction protein ZO-1. Am J Pathol (1992) 1.66
The role of podocytes in glomerular pathobiology. Clin Exp Nephrol (2003) 1.57
Increased Tyr phosphorylation of ZO-1 during modification of tight junctions between glomerular foot processes. Am J Physiol (1995) 1.45
Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol (1999) 1.42
Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies. Am J Pathol (2000) 1.12
Nephrin in experimental glomerular disease. Kidney Int (2000) 1.09
Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. J Am Soc Nephrol (2000) 1.07
Atopy, serum IgE, and interleukin-13 in steroid-responsive nephrotic syndrome. Pediatr Nephrol (2004) 1.06
Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Allergy (2001) 1.05
Interleukin-4 and interleukin-13 act on glomerular visceral epithelial cells. J Am Soc Nephrol (2000) 1.04
Slit diaphragm-reactive nephritogenic MAb 5-1-6 alters expression of ZO-1 in rat podocytes. Am J Physiol (1997) 1.02
Association of IL-13 polymorphisms with leukotriene receptor antagonist drug responsiveness in Korean children with exercise-induced bronchoconstriction. Pharmacogenet Genomics (2008) 0.92
Effects of advanced glycosylation endproducts on perlecan core protein of glomerular epithelium. Pediatr Nephrol (2004) 0.91
Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats. Yonsei Med J (2005) 0.89
Charge selectivity in kidney ultrafiltration. Kidney Int (1995) 0.89
Interleukin-13 genetic polymorphisms in Singapore Chinese children correlate with long-term outcome of minimal-change disease. Nephrol Dial Transplant (2005) 0.88
High-glucose and advanced glycosylation end products increased podocyte permeability via PI3-K/Akt signaling. J Mol Med (Berl) (2010) 0.87
Ginseng total saponin improves podocyte hyperpermeability induced by high glucose and advanced glycosylation endproducts. J Korean Med Sci (2011) 0.86
Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest (2002) 0.85
Cough, asthma, and cysteinyl-leukotrienes. Pulm Pharmacol Ther (2013) 0.84
The glomerular basement membrane charge-selectivity barrier: an oversimplified concept? Nephrol Dial Transplant (1996) 0.79
Montelukast: a novel therapeutic option in eosinophilic peritonitis. Pediatr Nephrol (2013) 0.78
[Molecular dynamics of proteins found exclusively in glomerular epithelial cells]. Rinsho Byori (2000) 0.76
Outcomes of Hemodialysis in Children: A 35-Year Experience at Severance Hospital. Yonsei Med J (2015) 0.75